Dose adjusted EPOCH-R is superior to RCHOP in frontline treatment of mediastinal large B cell lymphoma

Introduction Primary Mediastinal Large B Cell Lymphoma (PMLBCL) is a rare but aggressive B-cell lymphoma. This study compares the outcomes and toxicities of DA-EPOCH-R (Dose-adjusted etoposide, prednisolone, vincristine, cyclophosphamide, and doxorubicin in combination with rituximab) and RCHOP-21 (...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής

Κύριοι συγγραφείς:	Mohammad Ma'koseh, Abeer Yaseen, Nebras Abu Abed, Omar Shahin, Alaa Abufara, Khalid Halahleh, Mohammad Al-Rwashdeh, Zaid Abdel Rahman, Ro’a Muqbel, Heba Farfoura, Akram Al-Ibraheem, Kamal Al-rabi, Hikmat Abdel-Razeq
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	Taylor & Francis Group 2025-12-01
Σειρά:	Hematology
Θέματα:	Mediastinal large B-cell lymphoma DA-EPOCH-R RCHOP Radiotherapy aa-IPI relapse
Διαθέσιμο Online:	https://www.tandfonline.com/doi/10.1080/16078454.2025.2515337
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!